Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
New research from the National Eczema Association reveals that eczema patients and caregivers want to be involved in decision-making for their treatments.
New research from the National Eczema Association reveals that eczema patients and caregivers want to be involved in decision-making for their treatments.
Drs Hao Feng and Eric Beltrami discussed the travel and time burdens surrounding psoriasis clinical sites following their study, “Differential Patient Travel Distance and Time to Psoriasis Clinical Trial Sites.”
Drs Hao Feng and Eric Beltrami discussed the travel and time burdens surrounding psoriasis clinical sites following their study, “Differential Patient Travel Distance and Time to Psoriasis Clinical Trial Sites.”
Following her recent study, Dr Abigail Cline discusses what further research is needed to evaluate dupilumab’s effectiveness and the occurrence of adverse effects.
Following her recent study, Dr Abigail Cline discusses what further research is needed to evaluate dupilumab’s effectiveness and the occurrence of adverse effects.
A recent study published in JAMA Dermatology has unveiled a potentially critical link between atopic dermatitis and inflammatory bowel disease, which includes ulcerative colitis and Crohn disease.
A recent study published in JAMA Dermatology has unveiled a potentially critical link between atopic dermatitis and inflammatory bowel disease, which includes ulcerative colitis and Crohn disease.
There is a need for a plaque psoriasis topical treatment that is proven and well tolerated for long-term use, even on sensitive areas of skin, that may allow patients to take a “drug vacation” and experience significantly clearer skin while...
There is a need for a plaque psoriasis topical treatment that is proven and well tolerated for long-term use, even on sensitive areas of skin, that may allow patients to take a “drug vacation” and experience significantly clearer skin while...
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...